Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer

被引:0
作者
Son, Ji [1 ]
Cain, Katherine E. [2 ]
Marten, Claire A. [2 ]
Dwyer, Kaitlin W. [1 ]
Sims, Travis T. [1 ]
Taylor, Jolyn S. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pharm Clin Programs, Houston, TX USA
来源
GYNECOLOGIC ONCOLOGY REPORTS | 2024年 / 56卷
关键词
SQUAMOUS-CELL-CARCINOMA; PREVIOUSLY TREATED RECURRENT; PHASE-II; TISSUE FACTOR; PERSISTENT; TRIAL;
D O I
10.1016/j.gore.2024.101525
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy
    Cohen, Alexander C.
    Roane, Brandon M.
    Leath, Charles A., III
    DRUGS, 2020, 80 (03) : 217 - 227
  • [32] Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
    He, Ying
    Wang, Jing
    Xie, Shuangshuang
    Xue, Qianlong
    FRONTIERS IN SURGERY, 2022, 9
  • [33] Recurrent cervical cancer presented with lymphangitic carcinomatosis
    Baiocchi, Glauco
    Neto, Renato Cagnacci
    Fukazawa, Elza Mieko
    Faloppa, Carlos Chaves
    Avertano-Rocha, Antonio Bomfim
    Begnami, Maria Dirlei
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (05) : 1130 - 1132
  • [34] Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review
    Wu, Yuke
    He, Xiang
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (07)
  • [35] Management of Recurrent Cervical Papillary Thyroid Cancer
    Goyal, Rachna M.
    Jonklaas, Jacqueline
    Burman, Kenneth D.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (02) : 565 - +
  • [36] Management of recurrent cervical cancer: A review of the literature
    Peiretti, M.
    Zapardiel, I.
    Zanagnolo, V.
    Landoni, F.
    Morrow, C. P.
    Maggioni, A.
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (02): : E59 - E66
  • [37] Treatment options in recurrent cervical cancer (Review)
    Gadducci, Angiolo
    Tana, Rerta
    Cosio, Stefania
    Cionini, Luca
    ONCOLOGY LETTERS, 2010, 1 (01) : 3 - 11
  • [38] New therapeutic approaches in recurrent cervical cancer
    Koensgen, Dominique
    Battista, Marco J.
    Egger, Eva Katharina
    Krajnak, Slavomir
    Heimes, Anne-Sophie
    Schmidt, Marcus
    Keyver-Paik, Mignon-Denise
    Hasenburg, Annette
    Mustea, Alexander
    ONKOLOGE, 2020, 26 (07): : 623 - 629
  • [39] Surgical management of advanced and recurrent cervical cancer
    Estape, R
    Angioli, R
    SEMINARS IN SURGICAL ONCOLOGY, 1999, 16 (03): : 236 - 241
  • [40] Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer
    Wolford, Juliet E.
    Tewari, Krishnansu S.
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (05) : 445 - 457